Eslicarbazepine acetate add-on for drug-resistant partial epilepsy.
CONCLUSIONS: ESL reduces seizure frequency when used as an add-on treatment for people with drug-resistant partial epilepsy. The trials included in this review were of short-term duration and focused on adults. One new trial has been included in this update, but the conclusions are unchanged.
PMID: 29067682 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Chang XC, Yuan H, Wang Y, Xu HQ, Hong WK, Zheng RY Tags: Cochrane Database Syst Rev Source Type: research